메뉴 건너뛰기




Volumn 37, Issue 7, 2017, Pages 781-790

Characterization and Management of Patients with Heroin versus Nonheroin Opioid Overdoses: Experience at an Academic Medical Center

Author keywords

academic medical center; heroin; naloxone; opioid overdose; overdose demographics; prescription opioid

Indexed keywords

DIAMORPHINE; NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT;

EID: 85013968878     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1902     Document Type: Article
Times cited : (17)

References (23)
  • 2
    • 84973091471 scopus 로고    scopus 로고
    • The toxicology of heroin-related death: estimating survival times
    • Darke S, Duflou J. The toxicology of heroin-related death: estimating survival times. Addiction 2016;111(9):1607–13.
    • (2016) Addiction , vol.111 , Issue.9 , pp. 1607-1613
    • Darke, S.1    Duflou, J.2
  • 4
    • 33846341115 scopus 로고    scopus 로고
    • Prescription naloxone: a novel approach to heroin overdose prevention
    • Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007;49(2):172–7.
    • (2007) Ann Emerg Med , vol.49 , Issue.2 , pp. 172-177
    • Sporer, K.A.1    Kral, A.H.2
  • 5
    • 84961288180 scopus 로고    scopus 로고
    • Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access
    • Wermeling DP. Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Ther Adv Drug Saf 2015;6(1):20–31.
    • (2015) Ther Adv Drug Saf , vol.6 , Issue.1 , pp. 20-31
    • Wermeling, D.P.1
  • 6
    • 77954121512 scopus 로고    scopus 로고
    • Opioid harm reduction strategies: focus on expanded access to intranasal naloxone
    • Wermeling DP. Opioid harm reduction strategies: focus on expanded access to intranasal naloxone. Pharmacotherapy 2010;30(7):627–31.
    • (2010) Pharmacotherapy , vol.30 , Issue.7 , pp. 627-631
    • Wermeling, D.P.1
  • 7
    • 73449108112 scopus 로고    scopus 로고
    • Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006
    • Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief 2009;22:1–8.
    • (2009) NCHS Data Brief , vol.22 , pp. 1-8
    • Warner, M.1    Chen, L.H.2    Makuc, D.M.3
  • 8
    • 34248232024 scopus 로고    scopus 로고
    • US data show sharply rising drug-induced death rates
    • Paulozzi LJ, Annest JL. US data show sharply rising drug-induced death rates. Inj Prev 2007;13(2):130–2.
    • (2007) Inj Prev , vol.13 , Issue.2 , pp. 130-132
    • Paulozzi, L.J.1    Annest, J.L.2
  • 9
    • 84874002897 scopus 로고    scopus 로고
    • Pharmaceutical overdose deaths, United States, 2010
    • Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309(7):657–9.
    • (2013) JAMA , vol.309 , Issue.7 , pp. 657-659
    • Jones, C.M.1    Mack, K.A.2    Paulozzi, L.J.3
  • 10
    • 84881261103 scopus 로고    scopus 로고
    • National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009
    • Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend 2013;131(3):263–70.
    • (2013) Drug Alcohol Depend , vol.131 , Issue.3 , pp. 263-270
    • Calcaterra, S.1    Glanz, J.2    Binswanger, I.A.3
  • 11
    • 84857382804 scopus 로고    scopus 로고
    • Community-based opioid overdose prevention programs providing naloxone—United States, 2010
    • Centers for Disease Control and Prevention. Community-based opioid overdose prevention programs providing naloxone—United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61(6):101–5.
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , Issue.6 , pp. 101-105
  • 12
    • 57449112519 scopus 로고    scopus 로고
    • Patterns of abuse among unintentional pharmaceutical overdose fatalities
    • Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300(22):2613–20.
    • (2008) JAMA , vol.300 , Issue.22 , pp. 2613-2620
    • Hall, A.J.1    Logan, J.E.2    Toblin, R.L.3
  • 13
    • 33748998767 scopus 로고    scopus 로고
    • Naloxone use in a tiered-response emergency medical services system
    • Belz D, Lieb J, Rea T, Eisenberg MS. Naloxone use in a tiered-response emergency medical services system. Prehosp Emerg Care 2006;10(4):468–71.
    • (2006) Prehosp Emerg Care , vol.10 , Issue.4 , pp. 468-471
    • Belz, D.1    Lieb, J.2    Rea, T.3    Eisenberg, M.S.4
  • 14
    • 38849179295 scopus 로고    scopus 로고
    • Intranasal naloxone for the treatment of suspected heroin overdose
    • Kerr D, Dietze P, Kelly AM. Intranasal naloxone for the treatment of suspected heroin overdose. Addiction 2008;103(3):379–86.
    • (2008) Addiction , vol.103 , Issue.3 , pp. 379-386
    • Kerr, D.1    Dietze, P.2    Kelly, A.M.3
  • 15
    • 33748455452 scopus 로고    scopus 로고
    • Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths
    • Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006;25(3):89–96.
    • (2006) J Addict Dis , vol.25 , Issue.3 , pp. 89-96
    • Maxwell, S.1    Bigg, D.2    Stanczykiewicz, K.3    Carlberg-Racich, S.4
  • 16
    • 0000461485 scopus 로고    scopus 로고
    • Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose
    • Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med 1998;5(4):293–9.
    • (1998) Acad Emerg Med , vol.5 , Issue.4 , pp. 293-299
    • Wanger, K.1    Brough, L.2    Macmillan, I.3    Goulding, J.4    MacPhail, I.5    Christenson, J.M.6
  • 17
    • 77953673796 scopus 로고    scopus 로고
    • Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008
    • Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. MMWR Morb Mortal Wkly Rep 2010;59(23):705–9.
    • (2010) MMWR Morb Mortal Wkly Rep , vol.59 , Issue.23 , pp. 705-709
  • 18
    • 84926145583 scopus 로고    scopus 로고
    • Trends in abuse and misuse of prescription opioids among older adults
    • West NA, Severtson SG, Green JL, Dart RC. Trends in abuse and misuse of prescription opioids among older adults. Drug Alcohol Depend 2015;149:117–21.
    • (2015) Drug Alcohol Depend , vol.149 , pp. 117-121
    • West, N.A.1    Severtson, S.G.2    Green, J.L.3    Dart, R.C.4
  • 19
    • 62049084378 scopus 로고    scopus 로고
    • Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support
    • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377–81.
    • (2009) J Biomed Inform , vol.42 , Issue.2 , pp. 377-381
    • Harris, P.A.1    Taylor, R.2    Thielke, R.3    Payne, J.4    Gonzalez, N.5    Conde, J.G.6
  • 20
    • 84885959418 scopus 로고    scopus 로고
    • Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial
    • Strang J, Bird SM, Parmar MK. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial. J Urban Health 2013;90(5):983–96.
    • (2013) J Urban Health , vol.90 , Issue.5 , pp. 983-996
    • Strang, J.1    Bird, S.M.2    Parmar, M.K.3
  • 21
    • 84903997684 scopus 로고    scopus 로고
    • The changing face of heroin use in the United States: a retrospective analysis of the past 50 years
    • Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014;71(7):821–6.
    • (2014) JAMA Psychiatry , vol.71 , Issue.7 , pp. 821-826
    • Cicero, T.J.1    Ellis, M.S.2    Surratt, H.L.3    Kurtz, S.P.4
  • 22
    • 84937010777 scopus 로고    scopus 로고
    • Vital signs: demographic and substance use trends among heroin users—United States, 2002–2013
    • Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users—United States, 2002–2013. MMWR Morb Mortal Wkly Rep 2015;64(26):719–25.
    • (2015) MMWR Morb Mortal Wkly Rep , vol.64 , Issue.26 , pp. 719-725
    • Jones, C.M.1    Logan, J.2    Gladden, R.M.3    Bohm, M.K.4
  • 23
    • 84920996938 scopus 로고    scopus 로고
    • Trends in opioid analgesic abuse and mortality in the United States
    • Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015;372(3):241–8.
    • (2015) N Engl J Med , vol.372 , Issue.3 , pp. 241-248
    • Dart, R.C.1    Surratt, H.L.2    Cicero, T.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.